chlordiazepoxide has been researched along with zopiclone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Joly, D; Sanger, DJ; Zivkovic, B | 1 |
| Joly, D; Sanger, DJ | 1 |
| Barrett, JE; Brady, LS; Mansbach, RS; Stanley, JA; Witkin, JM | 1 |
| Spealman, RD | 1 |
| Burgevin, MC; Ferris, O; Gauthier, A; Guérémy, C; Heaulme, M; Le Fur, G; Mizoule, J; Uzan, A | 1 |
| Blanchard, JC; Boireau, A; Julou, L | 2 |
| Mathiasen, LS; Mirza, NR; Rodgers, RJ | 1 |
13 other study(ies) available for chlordiazepoxide and zopiclone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drinking Behavior; Feeding Behavior; Male; Piperazines; Punishment; Pyrazoles; Rats; Rats, Inbred Strains; Reinforcement Schedule; Reinforcement, Psychology | 1985 |
Anxiolytic drugs and the acquisition of conditioned fear in mice.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Chlordiazepoxide; Conditioning, Psychological; Diazepam; Fear; Male; Mice; Motor Activity; Piperazines; Pyrazoles | 1985 |
Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-beta-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Behavior, Animal; Benzodiazepinones; Carbolines; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Female; Flumazenil; Food; Male; Piperazines; Punishment; Receptors, GABA-A; Saimiri | 1986 |
Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788.
Topics: Animals; Azabicyclo Compounds; Barbital; Benzodiazepines; Benzodiazepinones; Buspirone; Caffeine; Chlordiazepoxide; Cinanserin; Clozapine; Conditioning, Operant; Cyproheptadine; Diazepam; Diphenhydramine; Discrimination Learning; Electroshock; Flumazenil; Male; Midazolam; Muscimol; Nordazepam; Pentobarbital; Piperazines; Pyridazines; Pyrimidines; Saimiri; Tripelennamine | 1985 |
Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives).
Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Binding, Competitive; Cerebellar Cortex; Chlordiazepoxide; Conflict, Psychological; Cyclic AMP; Cyclic GMP; Diazepam; Hypnotics and Sedatives; Kinetics; Male; Motor Activity; Piperazines; Quinolines; Rats; Receptors, Drug; Receptors, GABA-A | 1981 |
Brain receptors and zopiclone.
Topics: Animals; Azabicyclo Compounds; Binding, Competitive; Brain; Cerebellum; Chlordiazepoxide; Diazepam; Flunitrazepam; Hippocampus; Hypnotics and Sedatives; In Vitro Techniques; Male; Mice; Nitrazepam; Piperazines; Rats; Receptors, Cell Surface; Receptors, Drug; Receptors, GABA-A | 1983 |
Brain receptors and zopiclone.
Topics: Animals; Azabicyclo Compounds; Barbiturates; Binding, Competitive; Brain; Chlordiazepoxide; Cyclic GMP; Diazepam; Flunitrazepam; Hippocampus; Hypnotics and Sedatives; In Vitro Techniques; Male; Piperazines; Rats; Receptors, Cell Surface; Receptors, Drug; Receptors, GABA-A | 1982 |
Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Benzodiazepinones; Chlordiazepoxide; Cues; Discrimination Learning; Fluorobenzenes; GABA Modulators; Generalization, Psychological; Male; Piperazines; Protein Subunits; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Triazoles; Zolpidem | 2006 |